Search

A study conducted at Bugando Medical Centre in Mwanza, Tanzania, by the Catholic University of Health and Allied Sciences, focused on the seroprevalence of human papillomavirus (HPV) 6, 11, 16, and 18 among pregnant women attending antenatal clinics. The research found that about two-thirds of pregnant women had antibodies against these HPV types, indicating previous exposure. The study concluded that vaccination programs should be emphasized to reduce HPV-related manifestations in this population. [Extracted from the article]

A recent study conducted at the Federal University of Para examined the presence of human papillomavirus (HPV) in vaginal samples from women undergoing ovarian stimulation. The study found that multiple HPV types were present in the vagina, with an increase in HPV positivity following hormone stimulation. The researchers identified eight HPV types, including two potentially new types. The study highlights the presence of diverse HPV types in reproductive-age women and their association with hormone stimulation. [Extracted from the article]

A recent study conducted by researchers at the University of Chile has found a positive relationship between the presence of human papillomavirus (HPV) and the upregulation of the cIAP2 protein in oropharyngeal cancers (OPCs). The study also revealed that cIAP2 promotes radioresistance, which is a concern in the treatment of head and neck cancers (HNCs). The researchers determined the expression of cIAP2 in 49 OPCs from Chilean patients and found a statistically significant association between HPV presence and cIAP2 expression. Additionally, knocking down cIAP2 in HPV-driven HNC cells increased their sensitivity to radiation-induced apoptosis, suggesting that cIAP2 could be a potential therapeutic target for radiation in HPV-driven HNC. [Extracted from the article]

A recent study conducted by Vaxart Inc. has explored the potential of therapeutic vaccination in targeting and eliminating human papillomavirus 16 (HPV 16)-positive tumors. The researchers developed mucosally delivered vaccines that encoded HPV16's oncogenic proteins E6 and E7, along with a molecular dsRNA adjuvant. In pre-clinical murine studies, the vaccines demonstrated significant reductions in tumor volume and increased survival rates. The study suggests that this mucosal vaccination approach could be a promising option for the treatment and prevention of human cervical cancer. [Extracted from the article]

A recent study conducted by researchers at the University of Nevada has found that the prevalence of high-risk strains of human papillomavirus (HPV) in the oral cavity may be higher than previously thought. The study focused on non-HPV16 and non-HPV18 strains, which are not covered by the nine-valent HPV vaccine. The researchers screened saliva samples and found that 72 out of 251 samples tested positive for high-risk strains such as HPV31, HPV33, HPV35, HPV52, and HPV58. Interestingly, there was a significant increase in the prevalence of these strains after the introduction of the nine-valent HPV vaccine. The study also revealed that the majority of HPV-positive samples were within the recommended vaccination age range. These findings provide new evidence and support for the effectiveness of the nine-valent HPV vaccine in covering additional high-risk HPV strains. [Extracted from the article]

A recent study conducted by researchers at the University of Texas MD Anderson Cancer Center explored the association between human papillomavirus (HPV) genotype and phylogenic clade with oropharyngeal cancer outcomes. The study found that non-HPV16 genotype and A7 clade were associated with worse overall survival (OS) in patients with M0 disease treated with curative intent. However, when adjusting for patient and tumor covariates, neither HPV genotype nor phylogenic clade were prognostic, suggesting that differences in outcomes may be related to distinct clinical profiles rather than inherent viral properties. This research provides valuable insights into the impact of specific HPV genotypes on patient outcomes and has implications for treatment de-intensification. [Extracted from the article]

A new report from researchers at the University of California San Francisco (UCSF) provides data on the prevalence of anal human papillomavirus (HPV) infection and anal high-grade squamous intraepithelial lesions (HSIL) among men who have sex with men (MSM) aged 50 and older. The study found that the incidence of anal cancer, which is caused by HPV, is highest among MSM living with HIV. The research suggests that older MSM should be considered for anal cancer screening, as treating anal HSIL can prevent anal cancer. The study was supported by the NIH National Cancer Institute. [Extracted from the article]

The article discusses the development of a web resource called APV9WR, which provides comprehensive information on Alpha papillomavirus 9 (APV9). APV9 is a virus that belongs to the Papillomaviridae family and is closely related to high-risk HPV-16 and other HPV strains. It is responsible for causing warts and malignant tumors, and is associated with 75% of cervical malignancies and pre-cancerous lesions worldwide. The web resource includes genomic and protein sequences, as well as information on genome alignment, phylogenetic analysis, codon usage, CpG islands, glycosylation sites, diagnostic primers, and potential therapeutic elements. The goal of the resource is to assist researchers and scientific groups in their work on APV9. [Extracted from the article]

A recent study conducted by researchers at the Autonomous University of Guerrero in Mexico explores the role of human papillomavirus 16 (HPV 16) integration in the development of cervical cancer. The study utilizes bioinformatics analysis to identify proteins associated with HPV 16 infection and their interaction with E6, a protein involved in cancer development. The researchers found that the expression of MAGI-1, a protein associated with HPV 16 integration, decreased with the progression of premalignant lesions to invasive squamous cell carcinoma. The study suggests that MAGI-1 expression could serve as a potential biomarker for distinguishing cells with HPV 16 integration and uterine cervical lesions associated with tumor progression. [Extracted from the article]

Researchers at Central South University have developed a nomogram that can predict the necessity of endocervical curettage (ECC) in women with human papillomavirus (HPV) 16/18 infection. The nomogram combines clinical characteristics with the assessment of paired boxed gene 1 methylation levels (PAX1m) to improve the accuracy of detecting high-grade squamous intraepithelial lesions or worse (HSIL +) through ECC. The study found that age, cytology, and PAX1 methylation levels were independent predictive factors for additional detection of HSIL + by ECC. The nomogram demonstrated high sensitivity and specificity, making it a valuable tool for guiding clinical decisions regarding ECC in HPV 16/18-positive women. [Extracted from the article]

New research from the University of Kansas explores the destabilization of human papillomavirus 16 (HPV16) virus-like particles (VLPs) caused by antimicrobial preservatives (APs) during the formulation development of recombinant vaccine candidates. The study evaluates different analytical approaches to monitor the structural integrity of HPV16 VLPs adsorbed to an aluminum-salt adjuvant. The researchers found that traditional protein analysis methods showed only modest correlations with in vitro potency losses, while alternative approaches such as competitive ELISA immunoassays and LC-MS peptide mapping provided a better understanding of the physicochemical events and molecular mechanisms involved in AP-induced destabilization of vaccine antigens. This research expands the limited analytical toolset available for characterizing adjuvant-adsorbed antigens and provides valuable insights into vaccine development. [Extracted from the article]

A recent study conducted by researchers at the Karolinska Institute examined the use of methylation markers in cervical cancer screening programs for women who have received the human papillomavirus (HPV) vaccine. The study found that methylation levels were generally low among HPV-vaccinated women with high-grade squamous intraepithelial lesions (HSIL), and no significant differences were observed in methylation levels of viral or host-cell genes between HSIL cases and controls. However, a significant difference in methylation levels was found when considering a combination of viral genes and EPB41L3. Further investigation is needed to understand the implications of these findings for the management of HSIL in HPV-vaccinated women. [Extracted from the article]

A recent study conducted by researchers at Fudan University focused on the role of human papillomavirus (HPV)-encoded miRNAs in cervical cancer. The study found that two specific miRNAs, HPV16-miR-H1 and HPV16-miR-H6, were highly expressed in both cervical cancer cells and tissue samples from HPV16-positive patients. These miRNAs were found to upregulate tumor progression-associated genes and modulate gene expression through enhancer activity. The study suggests that targeting HPV16-positive cervical cancer through therapeutic strategies that focus on these miRNAs and enhancers could be a promising approach. [Extracted from the article]

A preprint abstract from medrxiv.org discusses the interplay between human immunodeficiency virus (HIV), anal human papillomavirus (HPV), and anal microbiota in men who have sex with men and are living with HIV in Northern Taiwan. The study found that bacterial diversity was diminished in individuals living with HIV with low CD4+ T cells and abnormal anal cytology, compared to those with normal anal cytology. Enterobacteriaceae, Ruminococcus, and Bacilli were significantly abundant in individuals with low CD4+ T cells and abnormal anal cytology. The researchers suggest that these patients should be monitored for the development of anal precancerous lesions. [Extracted from the article]

A recent study conducted by the Catalan Institute of Oncology-IDIBELL has investigated the potential of HPV16 E6 seroprevalence as a biomarker for anal dysplasia and cancer screening. The study found that individuals with HPV16 E6 seropositivity had a 3.6-fold increased risk of high-grade squamous intraepithelial lesions (HSIL) and a 26.1-fold increased risk of anal cancer (AC). However, the study concluded that while HPV16 E6 seroprevalence shows promise as a potential biomarker for HPV-related AC, it may be more effective as a confirmation test alongside other diagnostic methods, particularly in high-risk populations. Further research is needed to explore alternative screening algorithms and the dynamics of HPV16 E6 seroconversion. [Extracted from the article]

A new report discusses research findings on Human Papillomavirus 16 (HPV 16) from Shiraz University of Medical Sciences in Iran. The study focused on cervical cancer, which is the fourth most common cancer among women worldwide. The researchers selected 218 females with high-risk HPV infection and negative cytology tests and divided them into two groups: HPV 16/18 and other high-risk HPV (OHrHPV). The study found that the HPV 16/18 group had more high-grade colposcopy results compared to the OHrHPV group. The researchers concluded that direct referral for colposcopy in the OHrHPV group helps identify missed diagnosed lesions and lost-to-follow-up patients. [Extracted from the article]

A pre-clinical study has shown that a mucosal rAd5 therapeutic vaccination could potentially eliminate tumors caused by human papillomavirus 16 (HPV). The study used recombinant, non-replicating human adenovirus type 5 (rAd5) vaccines that encoded the HPV16 oncogenic proteins E6 and E7, along with a molecular dsRNA adjuvant. In a mouse model, mice treated with these vaccines showed significant reductions in tumor volume and increased survival compared to untreated mice. The study suggests that mucosal rAd5 vaccines have the potential to be used therapeutically for the treatment and prevention of human cervical cancer caused by HPV. However, it is important to note that this study has not yet undergone peer review. [Extracted from the article]

A recent report from Calico Life Sciences LLC discusses the structure of the p53 degradation complex from Human Papillomavirus 16 (HPV16). The study focuses on the interaction between the HPV early protein 6 (E6), the E3-ligase E6AP, and the tumor suppressor p53. The researchers used cryoEM to determine the structure of the complex and found extensive protein-protein interactions between E6 and E6AP. This research provides insights into the molecular basis of the complex and its potential as a therapeutic target for HPV-induced cancers. The findings suggest that current strategies for disrupting the complex should be reevaluated. [Extracted from the article]

A researcher from Chulalongkorn University in Bangkok, Thailand, has conducted a study on human papillomavirus 16 (HPV 16) and its role in cervical cancer. The study found that nearly all cervical cancer cases are caused by infection with high-risk HPV types. The research focused on the gene LAMB3, which was found to be overexpressed in cervical cancer cells and implicated in cancer pathways and the PI3K-AKT signaling pathway. Knocking down LAMB3 decreased cell migration, invasion, and cell growth, while increasing apoptosis. The study concluded that LAMB3 promotes cervical cancer cell migration, invasion, and survival. [Extracted from the article]

A recent study conducted at the University Medical Center in Ljubljana, Slovenia, aimed to better understand the natural history of anogenital warts (AGWs) and the dynamics of human papillomavirus 6 (HPV6) and 11 infection in regional hairs. The study followed 32 male patients with AGWs and 32 healthy controls over a period of time, collecting AGW tissues and hair samples. The study found that the prevalence of HPV6/11 in hair samples was 19.9% in AGW patients and 0% in controls, with the highest prevalence in pubic hairs and the lowest in eyebrows. The presence of HPV6/11 in hairs was closely associated with clinically visible AGWs. The study also found that the sublineage HPV6 B1 showed higher clearance from hairs, and a high proportion of AGW patients experienced post-initial AGW episodes. Overall, the study provides valuable insights into the dynamics of HPV6/11 infection in AGW patients. [Extracted from the article]

A recent study conducted by researchers at the University of Montreal examined the association between human papillomavirus 16 (HPV16) viral load during pregnancy and preterm birth. The study used data from participants in the HERITAGE study and measured HPV16 viral load using the Linear Array assay and real-time polymerase chain reaction. The findings revealed a strong association between a high HPV16 viral load during pregnancy and preterm birth, suggesting a biological gradient that supports a causal association. This research provides valuable insights into the potential risks associated with HPV16 infection during pregnancy. [Extracted from the article]

A recent study conducted by researchers at McGill University in Montreal, Canada, examined the natural history and co-detection patterns of Human papillomaviruses (HPV) of the Betapapillomavirus and Alphapapillomavirus genera in cervical samples of adult women. The study found that betapapillomaviruses are commonly found in the cervicovaginal tract and that there is significant within-genus clustering but not cross-genus clustering. The research also suggested potentially different mechanisms of transmission for betapapillomavirus genital infections other than vaginal sex. The findings provide valuable insights into the risk factors and co-detection patterns of HPV in cervical samples, contributing to our understanding of HPV infections in women. [Extracted from the article]

This document provides information about a clinical study on the long-term effectiveness and immuno-persistence of a bivalent human papillomavirus (HPV) vaccine. The study aims to evaluate the vaccine's protective efficacy against future HPV infections and related diseases in girls aged 9-17 years. It will also investigate the persistence of vaccine-induced antibodies and the potential for type replacement/competition phenomena post-vaccination. The study is being conducted in China by Xiamen University in collaboration with Xiamen Innovax Biotech Co., Ltd and the Center for Disease Control and Prevention. The estimated enrollment is 2188, and the study is expected to be completed by December 31, 2026. [Extracted from the article]

A recent study conducted by researchers at Kasetsart University in Bangkok, Thailand, explored the inhibitory effects of three traditional medicines, KerraTM, KSTM, and MinozaTM, on human papillomavirus (HPV) infection and cervical cancer. The study found that all three traditional medicines effectively suppressed the growth of cancer cells, with KerraTM being the most potent anticancer agent. Additionally, KerraTM showed promise in inhibiting HPV-16 infection. However, further research is needed to better understand the biochemical mechanisms and pharmacological activity of KerraTM. This study suggests that KerraTM may have potential in the prevention and treatment of cervical cancer. [Extracted from the article]

A recent study conducted at Peking Union Medical College Hospital in China investigated the association between different HPV genotypes and ages with immediate histological cervical lesions in opportunistic screening patients. The study found that HPV16, 58, 52, 33, and 31/18 were the most common high-risk HPV types in cervical intraepithelial neoplasia (CIN) of different severities. HPV16 was the dominant genotype in both CIN2 and CIN3, and the peak incidence of CIN3 was observed in women aged 25-34 years. The study suggests that women aged 25-44 years should be recommended for normative screening, and a vaccine targeting these predominant genotypes could be significant for cervical cancer prevention in China. [Extracted from the article]

A study conducted by researchers at Fudan University in Shanghai, China, examined the safety of the Cervarix vaccine in Chinese girls and women aged 9-45 years. The study found that the vaccine was well tolerated, with no serious adverse events or immune-mediated diseases reported. Among the participants, 5.5% reported any adverse event following immunization, and 0.7% reported serious adverse events. The study concluded that overall, no safety concerns were identified, although rare adverse events may have been missed due to the sample size. The findings of this study provide valuable information on the safety of the Cervarix vaccine in the Chinese population. [Extracted from the article]

A recent study conducted by researchers at the University of Melbourne in Australia has developed a new method for detecting and quantifying human papillomavirus (HPV) 16 and 18 in self-collected anal samples. The researchers used a touchdown droplet digital polymerase chain reaction (ddPCR) assay, which showed high sensitivity and specificity in detecting HPV types. The assay has potential clinical applications for diagnosing, quantifying, and monitoring anal HPV infections. This research is important because the quantity of HPV is associated with disease outcome, and this new assay provides a more accurate and precise method for measuring HPV in anal samples. [Extracted from the article]

A recent study conducted at Weill Cornell Medicine in New York City explored the association between Torquetenovirus (TTV) in vaginal secretions and infertility. The study tested vaginal secretions from 46 women seeking treatment for infertility and found that TTV was identified in 16 of the women. The presence of TTV was negatively associated with Lactobacillus crispatus dominance in the vaginal microbiota. However, there was no significant association between TTV detection and the presence of alphapapillomavirus or Candida species. This research suggests that TTV detection in the vagina may serve as a biomarker for specific causes of infertility. [Extracted from the article]

A preprint abstract from biorxiv.org discusses the role of SAMHD1 (sterile alpha motif and histidine-aspartic domain HD-containing protein 1) in the life cycle of Human Papillomavirus 16 (HPV16). The study found that SAMHD1 is a restriction factor for HPV16 and is recruited to replicating viral DNA. The phosphorylation of SAMHD1 promotes its conversion into a homologous recombination factor, which is necessary for HPV16 replication. The researchers also discovered that targeting cellular phosphatases, such as protein phosphatase 2A (PP2A), could have therapeutic potential for the treatment of HPV infections and cancers. However, it is important to note that this preprint has not yet undergone peer review. [Extracted from the article]

A recent study conducted by researchers at the Naval Medical University in Shanghai, China, explores the development of a new vaccine for tuberculosis (TB). The current vaccine, Bacillus Calmette-Guerin (BCG), is effective in protecting infants and young children against certain types of TB but is ineffective in protecting adolescents and adults against pulmonary TB. The researchers used virus-like particles (VLPs) to construct chimeric HPV16L1/Ag85B VLPs, which displayed the extracellular domain of Ag85B, an immunogen from Mycobacterium tuberculosis, on their surface. The study found that the chimeric VLPs induced higher antibody and T cell immune responses compared to recombinant Ag85B, suggesting their potential as a novel vaccine platform for controlling TB infection. This research provides valuable insights for the development of improved TB vaccines, particularly in low-income and developing countries. [Extracted from the article]

Keywords: Bangkok; Thailand; Asia; Alphapapillomavirus; Cancer; Cervical Cancer; DNA Tumor Viruses; DNA Viruses; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncology; Papillomaviridae; Papillomavirus Infections; Risk and Prevention; Tumor Virus Infections; Vertebrate Viruses; Viral; Virology; Women's Health EN Bangkok Thailand Asia Alphapapillomavirus Cancer Cervical Cancer DNA Tumor Viruses DNA Viruses Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncology Papillomaviridae Papillomavirus Infections Risk and Prevention Tumor Virus Infections Vertebrate Viruses Viral Virology Women's Health 868 868 1 11/06/23 20231106 NES 231106 2023 NOV 7 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Investigators discuss new findings in DNA Viruses - Human Papillomavirus 16. New Human Papillomavirus 16 Study Findings Recently Were Reported by Researchers at Chulalongkorn University (High-risk Human Papillomavirus Detection Via Cobas® 4800 and Reba Hpv-id® Assays) Our findings reveal that the FDA-approved HR-HPVs detection assay is appropriate for screening women with HR-HPVs infection, and for predicting increased risk of cervical cancer progression.". [Extracted from the article]

Keywords: Rockville; State:Maryland; United States; North and Central America; Alphapapillomavirus; Cancer; Cervical Cancer; DNA Tumor Viruses; DNA Viruses; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncology; Papillomaviridae; Risk and Prevention; Vertebrate Viruses; Women's Health EN Rockville State:Maryland United States North and Central America Alphapapillomavirus Cancer Cervical Cancer DNA Tumor Viruses DNA Viruses Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncology Papillomaviridae Risk and Prevention Vertebrate Viruses Women's Health 1387 1387 1 10/30/23 20231103 NES 231103 2023 OCT 31 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Investigators publish new report on DNA Viruses - Human Papillomavirus 16. According to news reporting originating from Rockville, Maryland, by NewsRx correspondents, research stated, "The World Health Organization recommends human papillomavirus (HPV) testing for cervical screening. [Extracted from the article]

Keywords: Houston; State:Texas; United States; North and Central America; Alphapapillomavirus; DNA Tumor Viruses; DNA Viruses; Genetics; HIV/AIDS; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Immune System Diseases and Conditions; Papillomaviridae; Primate Lentiviruses; RNA Viruses; Retroviridae; Vertebrate Viruses; Viral Sexually Transmitted Diseases and Conditions EN Houston State:Texas United States North and Central America Alphapapillomavirus DNA Tumor Viruses DNA Viruses Genetics HIV/AIDS Health and Medicine Human Papillomavirus Human Papillomavirus 16 Immune System Diseases and Conditions Papillomaviridae Primate Lentiviruses RNA Viruses Retroviridae Vertebrate Viruses Viral Sexually Transmitted Diseases and Conditions 55 55 1 10/30/23 20231030 NES 231030 2023 OCT 30 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Current study results on Immune System Diseases and Conditions - HIV/AIDS have been published. Houston, State:Texas, United States, North and Central America, DNA Tumor Viruses, DNA Viruses, Genetics, HIV/AIDS, Health and Medicine, Human Papillomavirus, Human Papillomavirus 16, Alphapapillomavirus, Immune System Diseases and Conditions, Papillomaviridae, Primate Lentiviruses, RNA Viruses, Retroviridae, Vertebrate Viruses, Viral Sexually Transmitted Diseases and Conditions. [Extracted from the article]

Alphapapillomavirus, Cancer, DNA Tumor Viruses, DNA Viruses, Genetics, Head and Neck Cancer, Head and Neck Neoplasms, Health and Medicine, Human Papillomavirus, Oncogenic Viruses, Oncology, Papillomaviridae, Human Papillomavirus 16, Papillomavirus Infections, Tumor Virus Infections, Vertebrate Viruses, Viral, Virology Keywords for this news article include: Aristotle University of Thessaloniki, Thessaloniki, Greece, Europe, Viral, Genetics, Oncology, Virology, DNA Viruses, Papillomaviridae, DNA Tumor Viruses, Oncogenic Viruses, Vertebrate Viruses, Alphapapillomavirus, Health and Medicine, Head and Neck Cancer, Tumor Virus Infections, Head and Neck Neoplasms, Human Papillomavirus 16, Papillomavirus Infections. Keywords: Alphapapillomavirus; Cancer; DNA Tumor Viruses; DNA Viruses; Genetics; Head and Neck Cancer; Head and Neck Neoplasms; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncogenic Viruses; Oncology; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vertebrate Viruses; Viral; Virology EN Alphapapillomavirus Cancer DNA Tumor Viruses DNA Viruses Genetics Head and Neck Cancer Head and Neck Neoplasms Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncogenic Viruses Oncology Papillomaviridae Papillomavirus Infections Tumor Virus Infections Vertebrate Viruses Viral Virology 144 144 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on head and neck cancer is the subject of a new report. [Extracted from the article]

A preprint abstract from medrxiv.org discusses the use of cell-free DNA (cfDNA) for the detection of human papillomavirus-driven oropharyngeal cancer (HPV-OPC). The study compares two cfDNA purification methods and two digital PCR systems to establish a workflow optimized for low plasma volumes. The results show that the MagNA Pure 96 method had a higher cfDNA isolation efficiency compared to the QIAamp ccfDNA/RNA kit, and both digital PCR systems had comparable analytical sensitivity. The assay had a sensitivity of 80% for detecting HPV16 and HPV33 in the validation set, and it remained sensitive and highly specific even in low volume samples. This research has not yet undergone peer review. [Extracted from the article]

Keywords: Alphapapillomavirus; Cervical Intraepithelial Neoplasia; DNA Tumor Viruses; DNA Viruses; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Neoplasia; Papillomaviridae; Urogenital Diseases and Conditions; Vertebrate Viruses; Viral; Virology EN Alphapapillomavirus Cervical Intraepithelial Neoplasia DNA Tumor Viruses DNA Viruses Health and Medicine Human Papillomavirus Human Papillomavirus 16 Neoplasia Papillomaviridae Urogenital Diseases and Conditions Vertebrate Viruses Viral Virology 1003 1003 1 10/09/23 20231010 NES 231010 2023 OCT 10 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- A new study on cervical intraepithelial neoplasia is now available. According to news reporting originating from Dunedin, New Zealand, by NewsRx correspondents, research stated, "High-risk, cancer-causing human papillomavirus (HPV) types are associated with cervical precancer and cancer.". [Extracted from the article]

In the HPV 16 + and Other HR-HPV + groups, the incidence of HSIL + in postmenopausal patients was not significantly different from that in premenopausal patients. Keywords: Alphapapillomavirus; Colposcopy; DNA Tumor Viruses; DNA Viruses; Diagnostics and Screening; Genetics; Gynecologic Surgery; Gynecologic Surgical Procedures; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Obstetric Surgery; Obstetric Surgical Procedures; Papillomaviridae; Surgery; Vertebrate Viruses; Women's Health EN Alphapapillomavirus Colposcopy DNA Tumor Viruses DNA Viruses Diagnostics and Screening Genetics Gynecologic Surgery Gynecologic Surgical Procedures Health and Medicine Human Papillomavirus Human Papillomavirus 16 Obstetric Surgery Obstetric Surgical Procedures Papillomaviridae Surgery Vertebrate Viruses Women's Health 1249 1249 1 10/03/23 20231006 NES 231006 2023 OCT 6 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Current study results on human papillomavirus 16 have been published. [Extracted from the article]

We especially focused on the association of human papillomavirus (HPV) genotypes. Keywords: Alphapapillomavirus; Cancer; Cervical Cancer; DNA Tumor Viruses; DNA Viruses; Diagnostics and Screening; Genetics; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncology; Papillomaviridae; Risk and Prevention; Vertebrate Viruses; Women's Health EN Alphapapillomavirus Cancer Cervical Cancer DNA Tumor Viruses DNA Viruses Diagnostics and Screening Genetics Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncology Papillomaviridae Risk and Prevention Vertebrate Viruses Women's Health 695 695 1 09/25/23 20230926 NES 230926 2023 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on human papillomavirus 16 is the subject of a new report. [Extracted from the article]

Studies have shown that specific genotype lineages of oncogenic HPV are associated with variable risks for the development of cervical intraepithelial neoplasia (CIN2/CIN3) and cervical cancer." Keywords: Alphapapillomavirus; Cancer; Cervical Cancer; DNA Tumor Viruses; DNA Viruses; Genetics; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncogenic Viruses; Oncology; Papillomaviridae; Risk and Prevention; Vertebrate Viruses; Viral; Virology; Women's Health EN Alphapapillomavirus Cancer Cervical Cancer DNA Tumor Viruses DNA Viruses Genetics Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncogenic Viruses Oncology Papillomaviridae Risk and Prevention Vertebrate Viruses Viral Virology Women's Health 459 459 1 09/25/23 20230926 NES 230926 2023 SEP 26 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Data detailed on human papillomavirus 16 have been presented. [Extracted from the article]

Alphapapillomavirus, DNA Tumor Viruses, DNA Virus Infections, DNA Viruses, Epidemiology, Health and Medicine, Human Papillomavirus, Papillomaviridae, Human Papillomavirus 16, Risk and Prevention, Tumor Virus Infections, Papillomavirus Infections, Vertebrate Viruses, Viral, Virology Keywords: Alphapapillomavirus; DNA Tumor Viruses; DNA Virus Infections; DNA Viruses; Epidemiology; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Papillomaviridae; Papillomavirus Infections; Risk and Prevention; Tumor Virus Infections; Vertebrate Viruses; Viral; Virology EN Alphapapillomavirus DNA Tumor Viruses DNA Virus Infections DNA Viruses Epidemiology Health and Medicine Human Papillomavirus Human Papillomavirus 16 Papillomaviridae Papillomavirus Infections Risk and Prevention Tumor Virus Infections Vertebrate Viruses Viral Virology 5229 5229 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Researchers detail new data in human papillomavirus 16. [Extracted from the article]

The diagnostic methods compared against gold-standard were HPV-16-VL, HPV-18-VL, and HPV-16-18-VL co-testing, anal cytology, and qualitative HPV detection. Keywords: Alphapapillomavirus; Cytology; DNA Tumor Viruses; DNA Viruses; Diagnostics and Screening; Drugs and Therapies; HIV/AIDS; Health and Medicine; Human Papillomavirus 16; Immune System Diseases and Conditions; Microbiological Techniques; Papillomaviridae; Primate Lentiviruses; RNA Viruses; Retroviridae; Vertebrate Viruses; Viral; Viral Load; Viral Sexually Transmitted Diseases and Conditions; Virology; Virus; Virus Physiological Phenomena EN Alphapapillomavirus Cytology DNA Tumor Viruses DNA Viruses Diagnostics and Screening Drugs and Therapies HIV/AIDS Health and Medicine Human Papillomavirus 16 Immune System Diseases and Conditions Microbiological Techniques Papillomaviridae Primate Lentiviruses RNA Viruses Retroviridae Vertebrate Viruses Viral Viral Load Viral Sexually Transmitted Diseases and Conditions Virology Virus Virus Physiological Phenomena 152 152 1 09/11/23 20230911 NES 230911 2023 SEP 11 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- New study results on HIV/AIDS have been published. [Extracted from the article]

A ubiquitously used HPV-negative cervical adenocarcinoma cell line is C-33A. Another cervical cancer cell line is available for purchase from the American Type Culture Collection (ATCC), namely DoTc2 4510, described to be HPV-negative and thus as a model for a rare gynecological malignancy. Keywords: Alphapapillomavirus; Biotechnology; Cancer; Carcinomas; Cell Line; Cervical Cancer; DNA Tumor Viruses; DNA Viruses; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncology; Papillomaviridae; Vertebrate Viruses; Women's Health EN Alphapapillomavirus Biotechnology Cancer Carcinomas Cell Line Cervical Cancer DNA Tumor Viruses DNA Viruses Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncology Papillomaviridae Vertebrate Viruses Women's Health 33 33 1 08/28/23 20230831 NES 230831 2023 AUG 28 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- Data detailed on human papillomavirus 16 have been presented. [Extracted from the article]

Rockville, State:Maryland, United States, North and Central America, Alphapapillomavirus, Carcinogenesis, DNA Tumor Viruses, DNA Viruses, Genetics, Health and Medicine, Human Papillomavirus, Papillomaviridae, Human Papillomavirus 16, Vertebrate Viruses, Viral, Virology, Virus Keywords: Rockville; State:Maryland; United States; North and Central America; Alphapapillomavirus; Carcinogenesis; DNA Tumor Viruses; DNA Viruses; Genetics; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Papillomaviridae; Vertebrate Viruses; Viral; Virology; Virus EN Rockville State:Maryland United States North and Central America Alphapapillomavirus Carcinogenesis DNA Tumor Viruses DNA Viruses Genetics Health and Medicine Human Papillomavirus Human Papillomavirus 16 Papillomaviridae Vertebrate Viruses Viral Virology Virus 1047 1047 1 07/17/23 20230718 NES 230718 2023 JUL 18 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Researchers detail new data in DNA Viruses - Human Papillomavirus 16. [Extracted from the article]

Keywords: Alphapapillomavirus; Cancer; Cervical Cancer; DNA Tumor Viruses; DNA Viruses; Genetics; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncogenic Viruses; Oncology; Papillomaviridae; Papillomavirus Infections; Risk and Prevention; Tumor Virus Infections; Vertebrate Viruses; Viral; Virology; Women's Health EN Alphapapillomavirus Cancer Cervical Cancer DNA Tumor Viruses DNA Viruses Genetics Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncogenic Viruses Oncology Papillomaviridae Papillomavirus Infections Risk and Prevention Tumor Virus Infections Vertebrate Viruses Viral Virology Women's Health 337 337 1 07/10/23 20230711 NES 230711 2023 JUL 11 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- Researchers detail new data in human papillomavirus 16. According to news reporting originating from Cuenca, Ecuador, by NewsRx correspondents, research stated, "Human Papillomavirus (HPV) infection is associated with intraepithelial neoplasia and cervical cancer (CC).". [Extracted from the article]

Keywords: Alphapapillomavirus; DNA Tumor Viruses; DNA Viruses; Genetics; Human Papillomavirus; Human Papillomavirus 16; Oncogenic Viruses; Papillomaviridae; Vertebrate Viruses; Viral; Virology EN Alphapapillomavirus DNA Tumor Viruses DNA Viruses Genetics Human Papillomavirus Human Papillomavirus 16 Oncogenic Viruses Papillomaviridae Vertebrate Viruses Viral Virology 836 836 1 06/26/23 20230627 NES 230627 2023 JUN 27 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- New research on human papillomavirus 16 is the subject of a new report. Alphapapillomavirus, DNA Tumor Viruses, DNA Viruses, Genetics, Human Papillomavirus, Oncogenic Viruses, Papillomaviridae, Human Papillomavirus 16, Vertebrate Viruses, Viral, Virology. [Extracted from the article]

This study suggests that HPV and cigarette smoke interaction in HNC promotes SOD2 alterations, leading to increased DNA damage and, in turn, contributing to development of a different clinical entity." Keywords: Alphapapillomavirus; Cancer; DNA Damage; DNA Research; DNA Tumor Viruses; DNA Viruses; Deoxyribonucleic Acid; Epidemiology; Genetics; Head and Neck Cancer; Head and Neck Neoplasms; Health and Medicine; Human Papillomavirus; Human Papillomavirus 16; Oncogenic Viruses; Oncology; Papillomaviridae; Papillomavirus Infections; Proteomics; Risk and Prevention; Tumor Virus Infections; Vertebrate Viruses; Viral; Virology EN Alphapapillomavirus Cancer DNA Damage DNA Research DNA Tumor Viruses DNA Viruses Deoxyribonucleic Acid Epidemiology Genetics Head and Neck Cancer Head and Neck Neoplasms Health and Medicine Human Papillomavirus Human Papillomavirus 16 Oncogenic Viruses Oncology Papillomaviridae Papillomavirus Infections Proteomics Risk and Prevention Tumor Virus Infections Vertebrate Viruses Viral Virology 708 708 1 04/24/23 20230425 NES 230425 2023 APR 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Fresh data on head and neck cancer are presented in a new report. [Extracted from the article]

Keywords: Toulouse; France; Europe; Alphapapillomavirus; DNA Tumor Viruses; DNA Viruses; Dermatology; Health and Medicine; Human Papillomavirus 16; Lichen Planus; Lichen Sclerosus; Lichen Sclerosus et Atrophicus; Lichenoid Eruptions; Papilloma; Papillomaviridae; Skin Diseases and Conditions; Skin and Connective Tissue Diseases and Conditions; Vertebrate Viruses EN Toulouse France Europe Alphapapillomavirus DNA Tumor Viruses DNA Viruses Dermatology Health and Medicine Human Papillomavirus 16 Lichen Planus Lichen Sclerosus Lichen Sclerosus et Atrophicus Lichenoid Eruptions Papilloma Papillomaviridae Skin Diseases and Conditions Skin and Connective Tissue Diseases and Conditions Vertebrate Viruses 4848 4848 1 04/17/23 20230421 NES 230421 2023 APR 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Current study results on Skin Diseases and Conditions - Lichen Sclerosus et Atrophicus have been published. Toulouse, France, Europe, Alphapapillomavirus, DNA Tumor Viruses, DNA Viruses, Dermatology, Health and Medicine, Human Papillomavirus 16, Lichen Planus, Lichen Sclerosus, Lichen Sclerosus et Atrophicus, Papilloma, Papillomaviridae, Lichenoid Eruptions, Skin Diseases and Conditions, Skin and Connective Tissue Diseases and Conditions, Vertebrate Viruses. [Extracted from the article]